Literature DB >> 15456505

Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven) after allogenic bone marrow transplantation.

M Karimi, M Zakerinia, H N Khojasteh, M Ramzi, E Ahmad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15456505     DOI： 10.1111/j.1538-7836.2004.00917.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  3 in total

Review 1.  Chemical hemorrhagic cystitis: Diagnostic and therapeutic pitfalls (Review).

Authors:  Razvan-Cosmin Petca; Razvan-Ionut Popescu; Cristian Toma; Mihai Cristian Dumitrascu; Aida Petca; Florica Sandru; Calin Bogdan Chibelean
Journal:  Exp Ther Med       Date:  2021-04-14       Impact factor: 2.447

2.  Ineffective off-label use of recombinant activated factor VII in a case of bone-marrow transplantation-related gastrointestinal bleeding.

Authors:  P Eller; C Pechlaner; Cj Wiedermann
Journal:  Thromb J       Date:  2006-01-18

Review 3.  Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges.

Authors:  Heather Payne; Andrew Adamson; Amit Bahl; Jonathan Borwell; David Dodds; Catherine Heath; Robert Huddart; Rhona McMenemin; Prashant Patel; John L Peters; Andrew Thompson
Journal:  BJU Int       Date:  2013-11       Impact factor: 5.588
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.